Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 205-207

Informa Healthcare

Access to resources Recommend Favorite

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G.   Brunetto V.L.   Kilgore L.   Soper J.T.   McGehee R.   Olt G.   Lentz S.S.   Sorosky J.   Hsiu J.-G.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 147-153

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Brunetto V.L.   VanLe L.   Bell J.   Walker J.L.   Lee R.B.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 212-216

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Miller D.S.   Blessing J.A.   Lentz S.S.   Waggoner S.E.  

Gynecologic Oncology, Vol. 87, Iss. 3, 2002-12 ,pp. : 247-251

Academic Press

Access to resources Recommend Favorite

A Phase I Study of Weekly Cisplatin and Whole Abdominal Radiation for the Treatment of Stage III and IV Endometrial Carcinoma: A Gynecologic Oncology Group Pilot Study

By Reisinger S.A.   Asbury R.   Liao S.Y.   Homesley H.D.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 299-303

Academic Press

Access to resources Recommend Favorite